305 related articles for article (PubMed ID: 15892620)
1. Matrix metalloproteinases as therapeutic targets in cancer.
Vihinen P; Ala-aho R; Kähäri VM
Curr Cancer Drug Targets; 2005 May; 5(3):203-20. PubMed ID: 15892620
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
Vihinen P; Kähäri VM
Int J Cancer; 2002 May; 99(2):157-66. PubMed ID: 11979428
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase inhibitors.
Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase inhibitors.
Ramnath N; Creaven PJ
Curr Oncol Rep; 2004 Mar; 6(2):96-102. PubMed ID: 14751086
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.
Yang JS; Lin CW; Su SC; Yang SF
Expert Opin Drug Metab Toxicol; 2016; 12(2):191-200. PubMed ID: 26852787
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials.
Pavlaki M; Zucker S
Cancer Metastasis Rev; 2003; 22(2-3):177-203. PubMed ID: 12784996
[TBL] [Abstract][Full Text] [Related]
7. The role of matrix metalloproteinases in the pathophysiology and progression of human nervous system malignancies: a chance for the development of targeted therapeutic approaches?
Koutroulis I; Zarros A; Theocharis S
Expert Opin Ther Targets; 2008 Dec; 12(12):1577-86. PubMed ID: 19007324
[TBL] [Abstract][Full Text] [Related]
8. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
Zucker S; Cao J; Chen WT
Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
[TBL] [Abstract][Full Text] [Related]
9. Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer.
Piperigkou Z; Manou D; Karamanou K; Theocharis AD
Methods Mol Biol; 2018; 1731():325-348. PubMed ID: 29318564
[TBL] [Abstract][Full Text] [Related]
10. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
[TBL] [Abstract][Full Text] [Related]
11. Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug.
Mitsiades N; Poulaki V; Mitsiades CS; Anderson KC
Expert Opin Investig Drugs; 2001 Jun; 10(6):1075-84. PubMed ID: 11772236
[TBL] [Abstract][Full Text] [Related]
12. Progress in the development of matrix metalloproteinase inhibitors.
Tu G; Xu W; Huang H; Li S
Curr Med Chem; 2008; 15(14):1388-95. PubMed ID: 18537616
[TBL] [Abstract][Full Text] [Related]
13. Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer.
Zhong Y; Lu YT; Sun Y; Shi ZH; Li NG; Tang YP; Duan JA
Expert Opin Drug Discov; 2018 Jan; 13(1):75-87. PubMed ID: 29088927
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: an overview.
Chaudhary AK; Pandya S; Ghosh K; Nadkarni A
Mutat Res; 2013; 753(1):7-23. PubMed ID: 23370482
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases. Novel targets for directed cancer therapy.
Yu AE; Hewitt RE; Connor EW; Stetler-Stevenson WG
Drugs Aging; 1997 Sep; 11(3):229-44. PubMed ID: 9303281
[TBL] [Abstract][Full Text] [Related]
16. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.
Gialeli C; Theocharis AD; Karamanos NK
FEBS J; 2011 Jan; 278(1):16-27. PubMed ID: 21087457
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases: biologic activity and clinical implications.
Nelson AR; Fingleton B; Rothenberg ML; Matrisian LM
J Clin Oncol; 2000 Mar; 18(5):1135-49. PubMed ID: 10694567
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in patent anti-cancer agents targeting the matrix metalloproteinases (MMPs).
Li X; Wu JF
Recent Pat Anticancer Drug Discov; 2010 Jun; 5(2):109-41. PubMed ID: 19951249
[TBL] [Abstract][Full Text] [Related]
19. Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases.
St-Pierre Y; Couillard J; Van Themsche C
Expert Opin Ther Targets; 2004 Oct; 8(5):473-89. PubMed ID: 15469396
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases in tumor invasion.
Johansson N; Ahonen M; Kähäri VM
Cell Mol Life Sci; 2000 Jan; 57(1):5-15. PubMed ID: 10949577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
